Veröffentlichung der Machbarkeitsstudie zur Risikoevaluation der COVID-19-Impfstoffe

This procedure is a written question submitted to the German government requesting the publication of a feasibility study regarding the risk evaluation of COVID-19 vaccines. It seeks transparency on how the safety and risks of these vaccines are being monitored and assessed. This matter primarily affects public health authorities and citizens interested in the transparency of vaccine safety data and the scientific basis for public health decisions.